Software Maintenance Agreement
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Office of Acquisitions and Logistics Management, has issued a Notice of Intent to award a sole source contract to InVita Healthcare Technologies, Inc. for Software Maintenance, Support, and Server Upgrade Services for their proprietary HemaConnect and HemaComply systems. This action is justified under FAR 13.106-1(b)(1) due to InVita's exclusive ownership and expertise. Interested parties must submit capability statements by May 3, 2026, at 3:00 PM EST. This is not a request for competitive quotations.
Scope of Work
The requirement includes comprehensive services for HemaConnect, HemaComply-Lab Manager, and HemaComply-Lab Equipment Manager. Key tasks involve:
- Upgrading NIH's local hosting environment.
- Migrating databases.
- Configuring production and test environments.
- Implementing MySQL 8.
- Deploying updated software versions.
These services are critical for maintaining continuity of operations for donor management, product quality control, and patient-related data systems within the Department of Transfusion Medicine.
Contract & Timeline
- Type: Notice of Intent (Sole Source)
- Intended Awardee: HemaTerra Technologies, LLC d/b/a InVita Healthcare Technologies, Inc.
- Authority: FAR 13.106-1(b)(1) - Only One Responsible Source.
- Set-Aside: None (Sole Source Justification)
- Response Due: May 3, 2026, 3:00 PM EST
- Published: April 24, 2026
- Period of Performance: To be determined at time of award, covering system upgrade, migration, validation, and transition.
Justification for Sole Source
InVita Healthcare Technologies, Inc. is the original developer, owner, and sole provider of the proprietary HemaConnect and HemaComply software systems, retaining exclusive rights and intellectual property. The software is integrated with NIH's Blood Bank Computer System (BBCS) and supports critical patient and donor record management. No third-party resellers or authorized service providers exist. Only InVita possesses the technical expertise to perform necessary upgrades and migrations without disrupting mission-critical operations. Award to any other source would result in substantial cost duplication, unacceptable delays, and risks to patient safety and system integrity.
Responses to this Notice
Interested organizations may submit a capability statement demonstrating:
- Technical capability to perform software upgrades and support.
- Evidence of authorization to support InVita proprietary systems.
- Relevant past performance.
Point of Contact
Shasheshe Goolsby, Team Leader, Hospital and Laboratory Support Division, OALM. Email: shasheshe.goolsby@nih.gov, Phone: 301-827-4879.